OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
The FDA’s decision to hold off on granting approval for an implant to treat addiction to heroin and prescription painkillers from Titan Pharmaceuticals, Inc. (OTCBB: TTNP) is a bitter reminder to investors that the agency doesn’t always follow the recommendation … Continue reading →
Investors tend to take notice when an FDA advisory panel recommends approval for a particular treatment being developed by a biopharmaceutical company and yesterday’s late news regarding Titan Pharmaceuticals Inc. (OTCBB: TTNP) and the advancement of their subdermal implant of … Continue reading →
It seems that investors are cautiously optimistic about the future of Titan Pharmaceuticals, Inc. (OTCBB: TTNP), holding their position on the small biotechnology company ahead of their planned meeting with the FDA in the fall to review and discuss the … Continue reading →
Posted in Articles, OTC Bulletin Board, Penny Stocks
|
Tagged cns, fda, investors, new drug, otcbb, penny stocks, probuphine, proneura, suboxone, titan pharmaceuticals, ttnp
|
It would be hard to imagine Titan Pharmaceuticals, Inc. (OTCBB: TTNP) sitting in a better position than the one in which they currently reside as the biopharmaceutical company is poised to release what are expected to be favorable results from … Continue reading →
Posted in Articles, OTC Bulletin Board, Penny Stocks
|
Tagged biopharmaceutical, fda, investors, otcbb, penny stocks, probuphine, proneura, titan pharmaceuticals, ttnp
|
